Vitamin D and its analogue in treating Periodontal diseases
Vitamin D has the
ability to eliminate microbes through diverse mechanisms and biphasic effect on
gingival epithelial growth. In concentrations less than equal to10 nM cell proliferation occurs and in 100 nM suppressed cell growth, whereas Vitamin D analogue shows anti proliferation.
Vitamin D and its analogue are involved in wound healing, by activation of
vitamin D receptors and increased production of human cathelicidin LL-37.
Increase in LL-37 results antimicrobial effect and reduce pro-inflammatory
cytokines. These characteristics of Vitamin D proved to be beneficial in
treating periodontal diseases.
A variety of pathways for the “perioprotective” function of
vitamin D have been elucidated. An important property of vitamin D is its
ability to induce the antimicrobial peptide, human cathelicidin LL-37, and
increase expression of the genes coding for microbial pattern recognition receptors.
LL-37 has the ability to eliminate microbes through diverse mechanisms, which
might play a key role in restricting the development of resistant bacterial
strains. In addition to its anti-microbial activities, LL-37 has been
demonstrated to elicit a plethora of pleiotropic effects. LL-37 has the ability
to strengthen the innate barrier, reduce pro-inflammatory cytokines, and
stimulate proliferation and migration of epithelial cells. LL-37 has also been
reported to inhibit in vitro osteoclastogenesis and down-regulate expression of
osteoclast genes. Monocytes, neutrophils and subsets of T lymphocytes have
chemotactic receptors that respond to LL-37. LL-37 induces proliferation and
migration of human epithelial cells and enhances activities which promote wound
healing. The topical use of vitamin D in psoriasis (chronic inflammatory
skin disease) has been shown to increase LL-37 levels and suppress the
production of pro-inflammatory cytokines IL-12/23, IL-1α, IL-1β, and TNF-α. Read more.........
Comments
Post a Comment